Abstract
Natural chemopreventive agents have long been validated to induce apoptosis in cancer cells. Extensive research is being conducted to elucidate the molecular pathways activated by natural agents and cause cellular death. They can act by directly suppressing molecules that inhibit apoptosis, activating pro-apoptotic proteins or by inhibiting pathways that promote survival. Understanding the mode of action of these natural compounds is of great value as this can lead to the development of targeted anti-cancer therapies. The use of natural agents as leads to develop chemotherapeutic drugs is preferred because of diminished side effects. This chapter focuses on natural compounds that have been established, by numerous studies, to be effective as anti-cancer agents. We describe the major apoptotic mechanisms of action of selected natural chemopreventive agents, including vitamin E, curcumin EGCG, quercetin, resveratrol and genistein. We also investigate the effects of these compounds in combination with natural or synthetic drugs. Finally, we take a detailed look at the efforts being made to incorporate these agents in nanoparticle formulations.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Akiyama T et al (1987) Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262(12):5592–5595
Alessi DR et al (1996) Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J 15(23):6541–6551
Alizadeh AM et al (2015) Encapsulation of curcumin in diblock copolymer micelles for cancer therapy. Biomed Res Int 2015:824746
Alotaibi A et al (2013) Tea phenols in bulk and nanoparticle form modify DNA damage in human lymphocytes from colon cancer patients and healthy individuals treated in vitro with platinum-based chemotherapeutic drugs. Nanomedicine (Lond) 8(3):389–401
Anand P et al (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4(6):807–818
Arabyan E et al (2018) Genistein inhibits African swine fever virus replication in vitro by disrupting viral DNA synthesis. Antiviral Res 156:128–137
Arya G, Das M, Sahoo SK (2018) Evaluation of curcumin loaded chitosan/PEG blended PLGA nanoparticles for effective treatment of pancreatic cancer. Biomed Pharmacother 102:555–566
Asanuma H et al (2005) Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells. Cancer Res 65(23):11018–11025
Ashkenazi A, Dixit VM (1998) Death receptors: signaling and modulation. Science 281(5381):1305–1308
Azandeh SS et al (2017) Anticancer activity of curcumin-loaded PLGA nanoparticles on PC3 prostate cancer cells. Iran J Pharm Res 16(3):868–879
Aziz MH et al (2006) Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3′-kinase/Akt pathway and Bcl-2 family proteins. Mol Cancer Ther 5(5):1335–1341
Bae Y, Kataoka K (2009) Intelligent polymeric micelles from functional poly(ethylene glycol)-poly(amino acid) block copolymers. Adv Drug Deliv Rev 61(10):768–784
Baechler SA et al (2016) Topoisomerase poisoning by genistein in the intestine of rats. Toxicol Lett 243:88–97
Bahi N et al (2006) Switch from caspase-dependent to caspase-independent death during heart development: essential role of endonuclease G in ischemia-induced DNA processing of differentiated cardiomyocytes. J Biol Chem 281(32):22943–22952
Baksi R et al (2018) In vitro and in vivo anticancer efficacy potential of quercetin loaded polymeric nanoparticles. Biomed Pharmacother 106:1513–1526
Bandele OJ, Osheroff N (2007) Bioflavonoids as poisons of human topoisomerase II alpha and II beta. Biochemistry 46(20):6097–6108
Benitez DA et al (2007) Non-genomic action of resveratrol on androgen and oestrogen receptors in prostate cancer: modulation of the phosphoinositide 3-kinase pathway. Br J Cancer 96(10):1595–1604
Bernabeu E et al (2016) Novel Soluplus((R))-TPGS mixed micelles for encapsulation of paclitaxel with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines. Colloids Surf B Biointerfaces 140:403–411
Bidere N et al (2003) Cathepsin D triggers Bax activation, resulting in selective apoptosis-inducing factor (AIF) relocation in T lymphocytes entering the early commitment phase to apoptosis. J Biol Chem 278(33):31401–31411
Bishayee K, Khuda-Bukhsh AR, Huh SO (2015) PLGA-loaded gold-nanoparticles precipitated with quercetin downregulate HDAC-Akt activities controlling proliferation and activate p53-ROS crosstalk to induce apoptosis in hepatocarcinoma cells. Mol Cells 38(6):518–527
Boldin MP et al (1995) Self-association of the “death domains” of the p55 tumor necrosis factor (TNF) receptor and Fas/APO1 prompts signaling for TNF and Fas/APO1 effects. J Biol Chem 270(1):387–391
Brown VA et al (2010) Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Res 70(22):9003–9011
Buki KG, Bauer PI, Kun E (1997) Isolation and identification of a proteinase from calf thymus that cleaves poly(ADP-ribose) polymerase and histone H1. Biochim Biophys Acta 1338(1):100–106
Burz C et al (2009) Apoptosis in cancer: key molecular signaling pathways and therapy targets. Acta Oncol 48(6):811–821
Cai L et al (2017) Folate receptor-targeted bioflavonoid genistein-loaded chitosan nanoparticles for enhanced anticancer effect in cervical cancers. Nanoscale Res Lett 12(1):509
Campana D et al (1993) Prolonged survival of B-lineage acute lymphoblastic leukemia cells is accompanied by overexpression of bcl-2 protein. Blood 81(4):1025–1031
Carstens MG, Rijcken CJ, Nostrum CF, Hennink WE (2008) Pharmaceutical micelles: combining longevity, stability, and stimuli sensitivity. In: Multifunctional pharmaceutical nanocarriers. Springer, New York, pp 263–308
Chan KKL et al (2018) Estrogen receptor modulators genistein, daidzein and ERB-041 inhibit cell migration, invasion, proliferation and sphere formation via modulation of FAK and PI3K/AKT signaling in ovarian cancer. Cancer Cell Int 18:65
Chang Z, Xing J, Yu X (2014) Curcumin induces osteosarcoma MG63 cells apoptosis via ROS/Cyto-C/Caspase-3 pathway. Tumour Biol 35(1):753–758
Chicheportiche Y et al (1997) TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem 272(51):32401–32410
Chinnaiyan AM (1999) The apoptosome: heart and soul of the cell death machine. Neoplasia 1(1):5–15
Choudhury H et al (2017) Recent advances in TPGS-based nanoparticles of docetaxel for improved chemotherapy. Int J Pharm 529(1–2):506–522
Chung SS et al (2018) Combination of resveratrol and 5-flurouracil enhanced anti-telomerase activity and apoptosis by inhibiting STAT3 and Akt signaling pathways in human colorectal cancer cells. Oncotarget 9(68):32943–32957
Cirman T et al (2004) Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins. J Biol Chem 279(5):3578–3587
Clancy AA et al (2010) Measuring properties of nanoparticles in embryonic blood vessels: towards a physicochemical basis for nanotoxicity. Chem Phys Lett 488(4-6):99–111
Cohen GM (1997) Caspases: the executioners of apoptosis. Biochem J 326(Pt 1):1–16
Constantinou A, Kiguchi K, Huberman E (1990) Induction of differentiation and DNA strand breakage in human HL-60 and K-562 leukemia cells by genistein. Cancer Res 50(9):2618–2624
Constantinou AI, Krygier AE, Mehta RR (1998a) Genistein induces maturation of cultured human breast cancer cells and prevents tumor growth in nude mice. Am J Clin Nutr 68(6 Suppl):1426S–1430S
Constantinou AI, Kamath N, Murley JS (1998b) Genistein inactivates bcl-2, delays the G2/M phase of the cell cycle, and induces apoptosis of human breast adenocarcinoma MCF-7 cells. Eur J Cancer 34(12):1927–1934
Constantinou C, Papas A, Constantinou AI (2008) Vitamin E and cancer: an insight into the anticancer activities of vitamin E isomers and analogs. Int J Cancer 123(4):739–752
Constantinou C, Papas KA, Constantinou AI (2009) Caspase-independent pathways of programmed cell death: the unraveling of new targets of cancer therapy? Curr Cancer Drug Targets 9(6):717–728
Couvreur P et al (1979) Adsorption of antineoplastic drugs to polyalkylcyanoacrylate nanoparticles and their release in calf serum. J Pharm Sci 68(12):1521–1524
Crawford A, Nahta R (2011) Targeting Bcl-2 in herceptin-resistant breast cancer cell lines. Curr Pharmacogenomics Person Med 9(3):184–190
Cullen SP, Martin SJ (2009) Caspase activation pathways: some recent progress. Cell Death Differ 16(7):935–938
Danial NN (2007) BCL-2 family proteins: critical checkpoints of apoptotic cell death. Clin Cancer Res 13(24):7254–7263
Degterev A, Boyce M, Yuan J (2003) A decade of caspases. Oncogene 22(53):8543–8567
de Pace RC et al (2013) Anticancer activities of (-)-epigallocatechin-3-gallate encapsulated nanoliposomes in MCF7 breast cancer cells. J Liposome Res 23(3):187–196
Dintaman JM, Silverman JA (1999) Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS). Pharm Res 16(10):1550–1556
Dorai T, Gehani N, Katz A (2000) Therapeutic potential of curcumin in human prostate cancer. II. Curcumin inhibits tyrosine kinase activity of epidermal growth factor receptor and depletes the protein. Mol Urol 4(1):1–6
Du K, Montminy M (1998) CREB is a regulatory target for the protein kinase Akt/PKB. J Biol Chem 273(49):32377–32379
Du C et al (2000) Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102(1):33–42
Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35(4):495–516
Elsabahy M, Wooley KL (2012) Design of polymeric nanoparticles for biomedical delivery applications. Chem Soc Rev 41(7):2545–2561
El Touny LH, Banerjee PP (2009) Identification of a biphasic role for genistein in the regulation of prostate cancer growth and metastasis. Cancer Res 69(8):3695–3703
Enari M et al (1998) A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391(6662):43–50
Esposti MD (2002) The roles of Bid. Apoptosis 7(5):433–440
Fang JY et al (2006) Effect of liposome encapsulation of tea catechins on their accumulation in basal cell carcinomas. J Dermatol Sci 42(2):101–109
Feng SS (2006) New-concept chemotherapy by nanoparticles of biodegradable polymers: where are we now? Nanomedicine (Lond) 1(3):297–309
Frojdo S et al (2007) Resveratrol is a class IA phosphoinositide 3-kinase inhibitor. Biochem J 406(3):511–518
Gao X et al (2012) Anticancer effect and mechanism of polymer micelle-encapsulated quercetin on ovarian cancer. Nanoscale 4(22):7021–7030
Gaonkar RH et al (2017) Garcinol loaded vitamin E TPGS emulsified PLGA nanoparticles: preparation, physicochemical characterization, in vitro and in vivo studies. Sci Rep 7(1)
Garrido C et al (2006) Mechanisms of cytochrome c release from mitochondria. Cell Death Differ 13(9):1423–1433
Geng T et al (2017) Resveratrol-loaded albumin nanoparticles with prolonged blood circulation and improved biocompatibility for highly effective targeted pancreatic tumor therapy. Nanoscale Res Lett 12(1):437
Ghiotto F, Fais F, Bruno S (2010) BH3-only proteins: the death-puppeteer’s wires. Cytometry A 77(1):11–21
Giam M, Huang DC, Bouillet P (2008) BH3-only proteins and their roles in programmed cell death. Oncogene 27(Suppl 1):S128–S136
Gobeil S et al (2001) Characterization of the necrotic cleavage of poly(ADP-ribose) polymerase (PARP-1): implication of lysosomal proteases. Cell Death Differ 8(6):588–594
Granado-Serrano AB et al (2006) Quercetin induces apoptosis via caspase activation, regulation of Bcl-2, and inhibition of PI-3-kinase/Akt and ERK pathways in a human hepatoma cell line (HepG2). J Nutr 136(11):2715–2721
Granja A, Pinheiro M, Reis S (2016) Epigallocatechin gallate nanodelivery systems for cancer therapy. Nutrients 8(5)
Gu Y et al (2016) Nanomicelles loaded with doxorubicin and curcumin for alleviating multidrug resistance in lung cancer. Int J Nanomedicine 11:5757–5770
Guicciardi ME, Gores GJ (2009) Life and death by death receptors. FASEB J 23(6):1625–1637
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674
Haque A et al (2015) Combination of erlotinib and EGCG induces apoptosis of head and neck cancers through posttranscriptional regulation of Bim and Bcl-2. Apoptosis 20(7):986–995
Hasan M et al (2014) Liposome encapsulation of curcumin: physico-chemical characterizations and effects on MCF7 cancer cell proliferation. Int J Pharm 461(1-2):519–528
Hastak K et al (2003) Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells. Oncogene 22(31):4851–4859
Hayakawa S et al (2001) Apoptosis induction by epigallocatechin gallate involves its binding to Fas. Biochem Biophys Res Commun 285(5):1102–1106
He B et al (2013) Quercetin liposome sensitizes colon carcinoma to thermotherapy and thermochemotherapy in mice models. Integr Cancer Ther 12(3):264–270
Hilchie AL et al (2010) Curcumin-induced apoptosis in PC3 prostate carcinoma cells is caspase-independent and involves cellular ceramide accumulation and damage to mitochondria. Nutr Cancer 62(3):379–389
Hill MM et al (2004) Analysis of the composition, assembly kinetics and activity of native Apaf-1 apoptosomes. EMBO J 23(10):2134–2145
Hinds MG, Day CL (2005) Regulation of apoptosis: uncovering the binding determinants. Curr Opin Struct Biol 15(6):690–699
Hirsch T et al (1997) The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene 15(13):1573–1581
Hong SJ, Dawson TM, Dawson VL (2004) Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signaling. Trends Pharmacol Sci 25(5):259–264
Hong JH et al (2006) The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo. Prostate Cancer Prostatic Dis 9(2):147–152
Hou W et al (2016) pH-Sensitive self-assembling nanoparticles for tumor near-infrared fluorescence imaging and chemo-photodynamic combination therapy. Nanoscale 8(1):104–116
Hsu H, Xiong J, Goeddel DV (1995) The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 81(4):495–504
Hu M, Zhu J, Qiu L (2014) Polymer micelle-based combination therapy of paclitaxel and resveratrol with enhanced and selective antitumor activity. RSC Adv 4:64151–64161
Hu YQ, Wang J, Wu JH (2016) Administration of resveratrol enhances cell-cycle arrest followed by apoptosis in DMBA-induced skin carcinogenesis in male Wistar rats. Eur Rev Med Pharmacol Sci 20(13):2935–2946
Huang H et al (2015) Combination of alpha-tomatine and curcumin inhibits growth and induces apoptosis in human prostate cancer cells. PLoS One 10(12):e0144293
Igney FH, Krammer PH (2002) Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer 2(4):277–288
Jacinto E et al (2006) SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 127(1):125–137
Jiao D et al (2016) Curcumin inhibited HGF-induced EMT and angiogenesis through regulating c-Met dependent PI3K/Akt/mTOR signaling pathways in lung cancer. Mol Ther Oncolytics 3:16018
Jin Z, El-Deiry WS (2005) Overview of cell death signaling pathways. Cancer Biol Ther 4(2):139–163
Jin X, Yang Q, Zhang Y (2017) Synergistic apoptotic effects of apigenin TPGS liposomes and tyroservatide: implications for effective treatment of lung cancer. Int J Nanomed 12:5109–5118
Joza N et al (2001) Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 410(6828):549–554
Jung KH et al (2015) Resveratrol-loaded polymeric nanoparticles suppress glucose metabolism and tumor growth in vitro and in vivo. Int J Pharm 478(1):251–257
Kamal-Eldin A, Appelqvist LA (1996) The chemistry and antioxidant properties of tocopherols and tocotrienols. Lipids 31(7):671–701
Kang SJ et al (2002) Distinct downstream pathways of caspase-11 in regulating apoptosis and cytokine maturation during septic shock response. Cell Death Differ 9(10):1115–1125
Karmakar S et al (2011) Induction of mitochondrial pathways and endoplasmic reticulum stress for increasing apoptosis in ectopic and orthotopic neuroblastoma xenografts. J Cancer Ther 2(2):77–90
Kaufmann SH (1998) Cell death induced by topoisomerase-targeted drugs: more questions than answers. Biochim Biophys Acta 1400(1-3):195–211
Kaufmann SH et al (1993) Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 53(17):3976–3985
Khan N et al (2014) Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model. Carcinogenesis 35(2):415–423
Khosravi-Far R, Esposti MD (2004) Death receptor signals to mitochondria. Cancer Biol Ther 3(11):1051–1057
Kim EJ et al (2008) Underlying mechanism of quercetin-induced cell death in human glioma cells. Neurochem Res 33(6):971–979
Kim TG et al (2009) Controlled release of paclitaxel from heparinized metal stent fabricated by layer-by-layer assembly of polylysine and hyaluronic acid-g-poly(lactic-co-glycolic acid) micelles encapsulating paclitaxel. Biomacromolecules 10(6):1532–1539
Kischkel FC et al (1995) Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 14(22):5579–5588
Klein JA et al (2002) The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature 419(6905):367–374
Koning GA, Storm G (2003) Targeted drug delivery systems for the intracellular delivery of macromolecular drugs. Drug Discov Today 8(11):482–483
Kothakota S et al (1997) Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 278(5336):294–298
Kowshik J et al (2014) Ellagic acid inhibits VEGF/VEGFR2, PI3K/Akt and MAPK signaling cascades in the hamster cheek pouch carcinogenesis model. Anticancer Agents Med Chem 14(9):1249–1260
Kumar S et al (2012) Nanotechnology as emerging tool for enhancing solubility of poorly water-soluble drugs. BioNanoScience 2(4):227–250. https://doi.org/10.1007/s12668-012-0060-7
Kumari A, Yadav SK, Yadav SC (2010) Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces 75(1):1–18
Kundur S et al (2019) Synergistic anticancer action of quercetin and curcumin against triple-negative breast cancer cell lines. J Cell Physiol 234(7):11103–11118
Kurosaka K et al (2003) Silent cleanup of very early apoptotic cells by macrophages. J Immunol 171(9):4672–4679
Labhasetwar V, Song CX, Levy RJ (1997) Nanoparticle drug delivery system for restenosis. Adv Drug Deliv Rev 24(1):63–85
Lennon SV, Martin SJ, Cotter TG (1991) Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli. Cell Prolif 24(2):203–214
Levine DH et al (2008) Polymersomes: a new multi-functional tool for cancer diagnosis and therapy. Methods 46(1):25–32
Li J, Yuan J (2008) Caspases in apoptosis and beyond. Oncogene 27(48):6194–6206
Li LY, Luo X, Wang X (2001) Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 412(6842):95–99
Li L, Braiteh FS, Kurzrock R (2005) Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 104(6):1322–1331
Li Y et al (2012) Curcumin inhibits proliferation and invasion of osteosarcoma cells through inactivation of Notch-1 signaling. FEBS J 279(12):2247–2259
Li X et al (2014) Preparation of curcumin micelles and the in vitro and in vivo evaluation for cancer therapy. J Biomed Nanotechnol 10(8):1458–1468
Li J et al (2016) Vitamin E TPGS modified liposomes enhance cellular uptake and targeted delivery of luteolin: an in vivo/in vitro evaluation. Int J Pharm 512(1):262–272
Liang C et al (2012) Genistein potentiates the anti-cancer effects of gemcitabine in human osteosarcoma via the downregulation of Akt and nuclear factor-kappaB pathway. Anticancer Agents Med Chem 12(5):554–563
Lin C et al (2012) Combination of quercetin with radiotherapy enhances tumor radiosensitivity in vitro and in vivo. Radiother Oncol 104(3):395–400
Liu S et al (2013) PI3K/AKT/mTOR signaling is involved in (-)-epigallocatechin-3-gallate-induced apoptosis of human pancreatic carcinoma cells. Am J Chin Med 41(3):629–642
Liu D et al (2014) Genistein enhances the effect of cisplatin on the inhibition of non-small cell lung cancer A549 cell growth in vitro and in vivo. Oncol Lett 8(6):2806–2810
Liu XX et al (2016) Genistein mediates the selective radiosensitizing effect in NSCLC A549 cells via inhibiting methylation of the keap1 gene promoter region. Oncotarget 7(19):27267–27279
Liu Y, Lin L, Song J, Zhao Y, Chao Z, Li H (2017) Preparation, characterization and anticanceractivities of resveratrol loaded redox-sensitive F127-SS-TOC micelles. RSC Adv 7:47091–47098
Long Q et al (2013) Induction of apoptosis and inhibition of angiogenesis by PEGylated liposomal quercetin in both cisplatin-sensitive and cisplatin-resistant ovarian cancers. J Biomed Nanotechnol 9(6):965–975
Lorenzo HK, Susin SA (2007) Therapeutic potential of AIF-mediated caspase-independent programmed cell death. Drug Resist Updat 10(6):235–255
Luthi AU, Martin SJ (2007) The CASBAH: a searchable database of caspase substrates. Cell Death Differ 14(4):641–650
Ma Y et al (2014) Combinational delivery of hydrophobic and hydrophilic anticancer drugs in single nanoemulsions to treat MDR in cancer. Mol Pharm 11(8):2623–2630
Ma YS et al (2018) Quercetin induced apoptosis of human oral cancer SAS cells through mitochondria and endoplasmic reticulum mediated signaling pathways. Oncol Lett 15(6):9663–9672
Macagnan FT, da Silva LP, Hecktheuer LH (2016) Dietary fibre: the scientific search for an ideal definition and methodology of analysis, and its physiological importance as a carrier of bioactive compounds. Food Res Int 85:144–154
Majno G, Joris I (1995) Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 146(1):3–15
Majumdar AP et al (2009) Curcumin synergizes with resveratrol to inhibit colon cancer. Nutr Cancer 61(4):544–553
Manning BD, Cantley LC (2007) AKT/PKB signaling: navigating downstream. Cell 129(7):1261–1274
Markovits J et al (1995) Genistein resistance in human leukaemic CCRF-CEM cells: selection of a diploid cell line with reduced DNA topoisomerase II beta isoform. Biochem Pharmacol 50(2):177–186
Mason KD et al (2008) In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas. Proc Natl Acad Sci USA 105(46):17961–17966
Meier MAR, Aerts SNH, Staal BBP, Rasa M, Schubert US (2005) PEO-b-PCL block copolymers: synthesis, detailed characterization, and selected micellar drug encapsulation behavior. Macromol Rapid Comm 26:1918–1924
Men K et al (2014) Nanoparticle-delivered quercetin for cancer therapy. Anti Cancer Agents Med Chem 14(6):826–832
Michael McClain R et al (2006) Genetic toxicity studies with genistein. Food Chem Toxicol 44(1):42–55
Moubarak RS et al (2007) Sequential activation of poly(ADP-ribose) polymerase 1, calpains, and Bax is essential in apoptosis-inducing factor-mediated programmed necrosis. Mol Cell Biol 27(13):4844–4862
Mu L, Feng SS (2002) Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol). J Control Release 80(1–3):129–144
Mu L, Elbayoumi TA, Torchilin VP (2005) Mixed micelles made of poly(ethylene glycol)-phosphatidylethanolamine conjugate and d-alpha-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin. Int J Pharm 306(1-2):142–149
Mukhopadhyay A et al (2001) Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines. Oncogene 20(52):7597–7609
Narayanan S et al (2014) Sequentially releasing dual-drug-loaded PLGA-casein core/shell nanomedicine: design, synthesis, biocompatibility and pharmacokinetics. Acta Biomater 10(5):2112–2124
Narayanan S et al (2015) Sequential release of epigallocatechin gallate and paclitaxel from PLGA-casein core/shell nanoparticles sensitizes drug-resistant breast cancer cells. Nanomedicine 11(6):1399–1406
Nassir AM et al (2018) Resveratrol-loaded PLGA nanoparticles mediated programmed cell death in prostate cancer cells. Saudi Pharm J 26(6):876–885
Neophytou CM, Constantinou AI (2015) Drug delivery innovations for enhancing the anticancer potential of vitamin E isoforms and their derivatives. Biomed Res Int 2015:584862
Neophytou CM et al (2014) D-alpha-tocopheryl polyethylene glycol succinate (TPGS) induces cell cycle arrest and apoptosis selectively in Survivin-overexpressing breast cancer cells. Biochem Pharmacol 89(1):31–42
Neuzil J (2003) Vitamin E succinate and cancer treatment: a vitamin E prototype for selective antitumour activity. Br J Cancer 89(10):1822–1826
Nguyen T et al (2014) Designing a better theranostic nanocarrier for cancer applications. Nanomedicine 9(15):2371–2386
Niu G et al (2011) Quercetin induces apoptosis by activating caspase-3 and regulating Bcl-2 and cyclooxygenase-2 pathways in human HL-60 cells. Acta Biochim Biophys Sin (Shanghai) 43(1):30–37
Northfelt DW et al (1998) Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi’s sarcoma: results of a randomized phase III clinical trial. J Clin Oncol 16(7):2445–2451
Pan J, Wang Y, Feng SS (2008) Formulation, characterization, and in vitro evaluation of quantum dots loaded in poly(lactide)-vitamin E TPGS nanoparticles for cellular and molecular imaging. Biotechnol Bioeng 101(3):622–633
Parhi P, Mohanty C, Sahoo SK (2011) Enhanced cellular uptake and in vivo pharmacokinetics of rapamycin-loaded cubic phase nanoparticles for cancer therapy. Acta Biomater 7(10):3656–3669
Peer D et al (2007) Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2(12):751–760
Peter ME, Krammer PH (1998) Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis. Curr Opin Immunol 10(5):545–551
Pham J, Brownlow B, Elbayoumi T (2013) Mitochondria-specific pro-apoptotic activity of genistein lipidic nanocarriers. Mol Pharm 10(10):3789–3800
Phan V et al (2013) Enhanced cytotoxicity of optimized liposomal genistein via specific induction of apoptosis in breast, ovarian and prostate carcinomas. J Drug Target 21(10):1001–1011
Plati J, Bucur O, Khosravi-Far R (2011) Apoptotic cell signaling in cancer progression and therapy. Integr Biol (Camb) 3(4):279–296
Pop C, Salvesen GS (2009) Human caspases: activation, specificity, and regulation. J Biol Chem 284(33):21777–21781
Pozo-Guisado E et al (2005) Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with downregulation of Bcl-2 and NF-kappa B. Int J Cancer 115(1):74–84. (Erratum in vol 116, pg 1004, 2005)
Prietsch RF et al (2014) Genistein induces apoptosis and autophagy in human breast MCF-7 cells by modulating the expression of proapoptotic factors and oxidative stress enzymes. Mol Cell Biochem 390(1-2):235–242
Ramadass SK et al (2015) Paclitaxel/epigallocatechin gallate coloaded liposome: a synergistic delivery to control the invasiveness of MDA-MB-231 breast cancer cells. Colloids Surf B Biointerfaces 125:65–72
Ranganathan S, Halagowder D, Sivasithambaram ND (2015) Quercetin suppresses twist to induce apoptosis in MCF-7 breast cancer cells. PLoS One 10(10):e0141370
Rapoport N (2004) Combined cancer therapy by micellar-encapsulated drug and ultrasound. Int J Pharm 277(1-2):155–162
Reimertz C et al (2001) Ca(2+)-induced inhibition of apoptosis in human SH-SY5Y neuroblastoma cells: degradation of apoptotic protease activating factor-1 (APAF-1). J Neurochem 78(6):1256–1266
Rouleau M et al (2010) PARP inhibition: PARP1 and beyond. Nat Rev Cancer 10(4):293–301
Ruan G, Feng SS (2003) Preparation and characterization of poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel. Biomaterials 24(27):5037–5044
Rubio-Moscardo F et al (2005) Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genes. Blood 106(9):3214–3222
Saelens X et al (2004) Toxic proteins released from mitochondria in cell death. Oncogene 23(16):2861–2874
Saelens X et al (2005) Protein synthesis persists during necrotic cell death. J Cell Biol 168(4):545–551
Saengkrit N et al (2014) Influence of curcumin-loaded cationic liposome on anticancer activity for cervical cancer therapy. Colloids Surf B Biointerfaces 114:349–356
Sah JF et al (2004) Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases. J Biol Chem 279(13):12755–12762
Sale EM, Sale GJ (2008) Protein kinase B: signalling roles and therapeutic targeting. Cell Mol Life Sci 65(1):113–127
Salti GI et al (2000) Genistein induces apoptosis and topoisomerase II-mediated DNA breakage in colon cancer cells. Eur J Cancer 36(6):796–802
Sarbassov DD et al (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307(5712):1098–1101
Savill J, Fadok V (2000) Corpse clearance defines the meaning of cell death. Nature 407(6805):784–788
Schimmer AD (2004) Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice. Cancer Res 64(20):7183–7190
Seo HS et al (2011) Phytoestrogens induce apoptosis via extrinsic pathway, inhibiting nuclear factor-kappaB signaling in HER2-overexpressing breast cancer cells. Anticancer Res 31(10):3301–3313
Sercombe L et al (2015) Advances and challenges of liposome assisted drug delivery. Front Pharmacol 6:286
Sharma G et al (2015) Methoxy poly(ethylene glycol)-poly(lactide) nanoparticles encapsulating quercetin act as an effective anticancer agent by inducing apoptosis in breast cancer. Pharm Res 32(2):723–735
She QB et al (2001) Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res 61(4):1604–1610
Shim JH et al (2008) (-)-Epigallocatechin gallate regulates CD3-mediated T cell receptor signaling in leukemia through the inhibition of ZAP-70 kinase. J Biol Chem 283(42):28370–28379
Siddiqui IA et al (2009) Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate. Cancer Res 69(5):1712–1716
Singh S, Aggarwal BB (1995) Activation of transcription factor Nf-kappa-B is suppressed by curcumin (diferulolylmethane). J Biol Chem 270(42):24995–25000
Singh SK et al (2017) Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/p21(WAF1/CIP1) and p27(KIP1) pathway. Oncotarget 8(10):17216–17228
Slee EA, Adrain C, Martin SJ (2001) Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J Biol Chem 276(10):7320–7326
Soldani C, Scovassi AI (2002) Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: an update. Apoptosis 7(4):321–328
Somanath PR et al (2009) The role of PAK-1 in activation of MAP kinase cascade and oncogenic transformation by Akt. Oncogene 28(25):2365–2369
Song G, Ouyang G, Bao S (2005) The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 9(1):59–71
Stambolic V et al (1998) Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95(1):29–39
Stephens L et al (1998) Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science 279(5351):710–714
Suliman A et al (2001) Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways. Oncogene 20(17):2122–2133
Sun L, Zhang C, Li P (2014) Copolymeric micelles for delivery of EGCG and cyclopamine to pancreatic cancer cells. Nutr Cancer 66(5):896–903
Sylvester PW (2007) Vitamin E and apoptosis. Vitam Horm 76:329–356
Tessitore L et al (2000) Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression. Carcinogenesis 21(8):1619–1622
Trump BF et al (1997) The pathways of cell death: oncosis, apoptosis, and necrosis. Toxicol Pathol 25(1):82–88
Vahsen N et al (2004) AIF deficiency compromises oxidative phosphorylation. EMBO J 23(23):4679–4689
Vanags DM et al (1996) Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis. J Biol Chem 271(49):31075–31085
Vancompernolle K et al (1998) Atractyloside-induced release of cathepsin B, a protease with caspase-processing activity. FEBS Lett 438(3):150–158
Vanden Berghe T et al (2004) Differential signaling to apoptotic and necrotic cell death by Fas-associated death domain protein FADD. J Biol Chem 279(9):7925–7933
van Hille B, Perrin D, Hill BT (1999) Differential in vitro interactions of a series of clinically useful topoisomerase-interacting compounds with the cleavage/religation activity of the human topoisomerase IIalpha and IIbeta isoforms. Anticancer Drugs 10(6):551–560
van Loo G et al (2002) The serine protease Omi/HtrA2 is released from mitochondria during apoptosis. Omi interacts with caspase-inhibitor XIAP and induces enhanced caspase activity. Cell Death Differ 9(1):20–26
Vazquez F et al (2000) Phosphorylation of the PTEN tail regulates protein stability and function. Mol Cell Biol 20(14):5010–5018
Vijayakumar MR et al (2016) Pharmacokinetics, biodistribution, in vitro cytotoxicity and biocompatibility of Vitamin E TPGS coated trans resveratrol liposomes. Colloids Surf B Biointerfaces 145:479–491
Wajant H (2002) The Fas signaling pathway: more than a paradigm. Science 296(5573):1635–1636
Wang JB et al (2009) Curcumin induces apoptosis through the mitochondria-mediated apoptotic pathway in HT-29 cells. J Zhejiang Univ Sci B 10(2):93–102
Wang XX et al (2011) The use of mitochondrial targeting resveratrol liposomes modified with a dequalinium polyethylene glycol-distearoylphosphatidyl ethanolamine conjugate to induce apoptosis in resistant lung cancer cells. Biomaterials 32(24):5673–5687
Wang S et al (2014) Epigallocatechin-3-gallate potentiates the effect of curcumin in inducing growth inhibition and apoptosis of resistant breast cancer cells. Am J Chin Med 42(5):1279–1300
Wang S et al (2015) mPEG-b-PCL/TPGS mixed micelles for delivery of resveratrol in overcoming resistant breast cancer. Expert Opin Drug Deliv 12(3):361–373
Wang Y et al (2017a) The functional curcumin liposomes induce apoptosis in C6 glioblastoma cells and C6 glioblastoma stem cells in vitro and in animals. Int J Nanomed 12:1369–1384
Wang W et al (2017b) Anticancer effects of resveratrol-loaded solid lipid nanoparticles on human breast cancer cells. Molecules 22(11)
Wang YR et al (2018) Barbaloin loaded polydopamine-polylactide-TPGS (PLA-TPGS) nanoparticles against gastric cancer as a targeted drug delivery system: studies in vitro and in vivo. Biochem Biophys Res Commun 499(1):8–16
Weeds AG et al (1986) Preparation and characterization of pig plasma and platelet gelsolins. Eur J Biochem 161(1):69–76
Win KY, Feng SS (2006) In vitro and in vivo studies on vitamin E TPGS-emulsified poly(D,L-lactic-co-glycolic acid) nanoparticles for paclitaxel formulation. Biomaterials 27(10):2285–2291
Wissing SA, Muller RH (2003) The influence of solid lipid nanoparticles on skin hydration and viscoelasticity—in vivo study. Eur J Pharm Biopharm 56(1):67–72
Xu W, Ling P, Zhang T (2013) Polymeric micelles, a promising drug delivery system to enhance bioavailability of poorly water-soluble drugs. J Drug Deliv 2013:340315
Xu G et al (2015) Enhancing the anti-colon cancer activity of quercetin by self-assembled micelles. Int J Nanomed 10:2051–2063
Yamasaki M et al (2013) Genistein induces apoptotic cell death associated with inhibition of the NF-kappaB pathway in adult T-cell leukemia cells. Cell Biol Int 37(7):742–747
Yang X et al (2015) Curcumin-encapsulated polymeric micelles suppress the development of colon cancer in vitro and in vivo. Sci Rep 5:10322
Youle RJ, Strasser A (2008) The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9(1):47–59
Yuan ZP et al (2006) Liposomal quercetin efficiently suppresses growth of solid tumors in murine models. Clin Cancer Res 12(10):3193–3199
Zeiss CJ (2003) The apoptosis-necrosis continuum: insights from genetically altered mice. Vet Pathol 40(5):481–495
Zhang L et al (2008) Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther 83(5):761–769
Zhang X et al (2011) Akt, FoxO and regulation of apoptosis. Biochim Biophys Acta 1813(11):1978–1986
Zhang Z, Tan S, Feng SS (2012) Vitamin E TPGS as a molecular biomaterial for drug delivery. Biomaterials 33(19):4889–4906
Zhang Z et al (2013) Genistein induces G2/M cell cycle arrest and apoptosis via ATM/p53-dependent pathway in human colon cancer cells. Int J Oncol 43(1):289–296
Zhang J et al (2014) TPGS-g-PLGA/Pluronic F68 mixed micelles for tanshinone IIA delivery in cancer therapy. Int J Pharm 476(1-2):185–198
Zhang P et al (2017) Curcumin synergizes with 5-fluorouracil by impairing AMPK/ULK1-dependent autophagy, AKT activity and enhancing apoptosis in colon cancer cells with tumor growth inhibition in xenograft mice. J Exp Clin Cancer Res 36(1):190
Zhao MH et al (2017) Quercetin-loaded mixed micelles exhibit enhanced cytotoxic efficacy in non-small cell lung cancer in vitro. Exp Ther Med 14(6):5503–5508
Zhou N et al (2009) Genistein inhibition of topoisomerase IIalpha expression participated by Sp1 and Sp3 in HeLa cell. Int J Mol Sci 10(7):3255–3268
Zhou P et al (2017) Genistein induces apoptosis of colon cancer cells by reversal of epithelial-to-mesenchymal via a Notch1/NF-kappaB/slug/E-cadherin pathway. BMC Cancer 17(1):813
Zhu X, Anquillare ELB, Farokhzad OC, Shi J (2014) Polymer- and protein-based nanotechnologies for cancer theranostics. In: Chen X, Wong S (eds) Cancer theranostics. Academic, Oxford pp 419–436
Zhu WT et al (2017) Delivery of curcumin by directed self-assembled micelles enhances therapeutic treatment of non-small-cell lung cancer. Int J Nanomed 12:2621–2634
Acknowledgments
This work was supported by funding from the University of Cyprus and was co-funded by the European Regional Development Fund and the Republic of Cyprus through the Research and Innovation Foundation (Project: INTERNATIONAL/OTHER/0118/0017).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Neophytou, C.M., Gregoriou, Y., Constantinou, A.I. (2020). Pro-apoptotic Properties of Chemopreventive Agents. In: Pezzuto, J., Vang, O. (eds) Natural Products for Cancer Chemoprevention. Springer, Cham. https://doi.org/10.1007/978-3-030-39855-2_16
Download citation
DOI: https://doi.org/10.1007/978-3-030-39855-2_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-39854-5
Online ISBN: 978-3-030-39855-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)